Skip to content

BCAX

Bicara Therapeutics Inc. Common Stock

NASDAQ · USHealthcareBiotechnology
$27.63-0.47%

Price as of Jul 20, 2026

BCAX ownership

Bicara Therapeutics Inc. Common Stock ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
16
Net (3m)
-$3.0M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jul
Context3-month price +18.3%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 14, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerOption10,000$3.79
Jul 14, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerSell9,972$28.42
Jul 14, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerSell28$29.68
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerOption11,592$3.79
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerOption908$3.79
Jul 10, 2026Cohlhepp Ryandirector, officer: President and COOOption18,750$3.79
Jul 10, 2026Cohlhepp Ryandirector, officer: President and COOSell22,833$28.76
Jul 10, 2026Cohlhepp Ryandirector, officer: President and COOSell4,306$29.80
Jul 10, 2026Cohlhepp Ryandirector, officer: President and COOSell1,075$30.35
Jul 10, 2026Cohlhepp Ryandirector, officer: President and COOSell536$29.00
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerSell22,757$28.60
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerOption12,500$3.79
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerSell4,413$29.82
Jul 10, 2026Hyep Ivanofficer: Chief Financial OfficerSell830$30.31
Jun 10, 2026Bowden ChristopherdirectorGrant19,475$20.56
Jun 10, 2026Haviland KatedirectorGrant19,475$20.56
Jun 10, 2026Mazumdar-Shaw KirandirectorGrant19,475$20.56
Jun 10, 2026Robertson Scott M.directorGrant19,475$20.56
Jun 10, 2026POWELL MICHAELdirectorGrant19,475$20.56
Jun 10, 2026Simson JakedirectorGrant19,475$20.56
Jun 10, 2026RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Grant19,475$20.56
May 26, 2026Hyep Ivanofficer: Chief Financial OfficerOption9,200$3.79
May 26, 2026Hyep Ivanofficer: Chief Financial OfficerSell9,200$20.42
May 20, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerOption15,000$3.79
May 20, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerSell2,978$20.35
May 20, 2026Mazumdar Clairedirector, officer: Chief Executive OfficerSell12,022$19.96
May 18, 2026Cohlhepp Ryandirector, officer: President and COOSell4,500$20.29
May 18, 2026Cohlhepp Ryandirector, officer: President and COOOption8,000$3.79
May 18, 2026Cohlhepp Ryandirector, officer: President and COOSell8,000$20.29
May 12, 2026Schelman Williamofficer: Chief Medical OfficerGrant85,000$22.58

Source: BCAX SEC Form 4 filings, latest Jul 14, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their BCAX positions over the last 6 months (SEC Form 13F).

Increased
107
New positions
71
Reduced
75
Sold out
42
Largest moves
InstitutionActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Increased7.3MMay 15, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged7.0MFeb 17, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased6.6MMay 15, 2026
SIREN, L.L.C.Increased5.8MMay 14, 2026
VESTAL POINT CAPITAL, LPIncreased5.4MMay 15, 2026
SIREN, L.L.C.Unchanged5.2MFeb 13, 2026
DEEP TRACK CAPITAL, LPIncreased4.1MMay 15, 2026
VESTAL POINT CAPITAL, LPReduced3.6MFeb 17, 2026
FMR LLCIncreased3.3MFeb 17, 2026
JANUS HENDERSON GROUP PLCIncreased3.3MMay 18, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased3.2MFeb 19, 2026
RED TREE MANAGEMENT, LLCUnchanged3.2MFeb 11, 2026
RED TREE MANAGEMENT, LLCUnchanged3.2MApr 22, 2026
TPG GP A, LLCUnchanged3.0MFeb 13, 2026
TPG GP A, LLCUnchanged3.0MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.